The Top Reasons Gold Prices Could Rocket

Analysts remain bullish on gold. UBS for example believes gold could run even further and remain high “for longer than expected” on global uncertainty, as noted by CNBC. The analyst added the firm raised its forecast for gold next year from $1,850 to $2,100.  “An environment of negative real interest rates and global uncertainties, such … Continue reading “The Top Reasons Gold Prices Could Rocket”

Lithium Headed for Another Supply Crunch

Lithium could easily run into a massive supply crunch – again.  All thanks to electric vehicle (EV) sales that are growing much faster than anyone expected. In fact, according to a new study from the Boston Consulting Group, by 2025, EVs could account for a third of all auto sales.  By 2030, EVs could surpass … Continue reading “Lithium Headed for Another Supply Crunch”

Top Reasons to Consider the eSports Boom

Big things are happening in the eSports industry. And they don’t look to cool off any time soon. After all, eSports practically prints money these days. U.S. News & World Report says, “The global eSports audience is expected to double from 335 million in 2017 to 646 million by 2023, according to Business Insider. Newzoo, … Continue reading “Top Reasons to Consider the eSports Boom”

Teleconferencing Creating $400 Billion Opportunity

With or without the pandemic, demand for virtual teleconferencing is here to stay.  At the moment, millions of workers and students are using video chats and conferences to replace in person meetings, and meetings they can’t attend with the pandemic. There’s so much demand, Grandview Research says the global events market is worth $90 billion … Continue reading “Teleconferencing Creating $400 Billion Opportunity”

The Top Reasons People are Shifting to Plant-Based Foods

The plant-based food market could hit $74.2 billion by 2027 thanks to skyrocketing demand.  Analysts at Meticulous Research say the key driver for such growth is bigger demand for sustainable and nutritious foods, as reported by Green Queen, a trend fueled by the pandemic. In fact, “They said that the crisis has importantly underlined the … Continue reading “The Top Reasons People are Shifting to Plant-Based Foods”

The $100 Billion Psychedelics Opportunity

Psychedelic drugs aren’t just some “here today, gone tomorrow” phenomenon. Not by a long shot. Instead, such treatments – like psilocybin mushrooms — are only just beginning to boom. It’s part of the reason that Eight Capital estimates the total market for mental health treatment could be valued at up to $100 billion. Just days … Continue reading “The $100 Billion Psychedelics Opportunity”

Why the Telehealth Boom is Here to Stay

Telehealth opportunities have become even more explosive. For one, according to a an Updox survey of 2,000 patients, 42% said they’ve used telehealth services since the pandemic began. Up to 63% said they like telehealth because it limits potential exposure to other patients. Two, President Trump just signed an executive order to expand telehealth in … Continue reading “Why the Telehealth Boom is Here to Stay”

This is Why Apple Continues to Explode Higher

Shares of Apple (AAPL) continue to explode higher. For one, its earnings were far better than expectations.   EPS of $2.58 was better than estimates for $2.04.   Revenue of $59.69 billion beat estimates for $52.25 billion. iPhone revenue soared to $26.42 billion, as compared to estimate for $22.37 billion. Services revenue jumped to $13.16 billion, as … Continue reading “This is Why Apple Continues to Explode Higher”

Gold Prices Could Hit $2,000 This Week

Gold prices are rocketing higher. This morning, the metal is up to $1,943, up another $41 an ounce. All as investors seek safety from the pandemic.  At this point, gold could hit $2,000 within months, says Goldman Sachs. Others, including Bank of America, are calling for $3,000.  All on the heels of the growing pandemic threat, lower … Continue reading “Gold Prices Could Hit $2,000 This Week”

This is Why Shares of Moderna Just Fell 12%

Just this morning, Moderna (MRNA) was downgraded by JP Morgan on valuation concerns. In fact, analyst Cory Kasimov said that while he is bullish on the stock, MRNA can no longer support the stock’s valuation. On that news, MRNA fell $10.  However, the pullback may not last long thanks to strong COVID-19 study results.  Remember, … Continue reading “This is Why Shares of Moderna Just Fell 12%”